The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Natriuretic peptide system in human heart failure.
Abstract
BACKGROUND: Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP) are a family of structurally related peptides that participate in the integrated control of renal and cardiovascular function. Previous studies suggest a functional role for these hormonal peptides in cardiorenal regulation in congestive heart failure (CHF). METHODS AND RESULTS: The present studies were performed in normal subjects (n = 6) and in patients with mild (New York Heart Association [NYHA] class I to II, n = 20) and severe (NYHA class III to IV, n = 20) CHF by use of radioimmunoassay and immunohistochemical staining (IHCS). Plasma ANP was significantly increased in both mild and severe CHF compared with normal subjects. In contrast, plasma BNP was only moderately increased in the severe CHF group, and plasma CNP concentration was unchanged in CHF compared with normal subjects. Atrial tissue concentrations of the natriuretic peptides did not parallel circulating concentrations. ANP predominated in normal atrial tissue, but BNP predominated in CHF. In ventricular tissue, IHCS staining was present for all three peptides in normal ventricular myocardium and was markedly enhanced in CHF. CONCLUSIONS: These studies support a differential regulation of ANP, BNP, and CNP circulating concentrations and tissue activity in human CHF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Bold, A. J., Borenstein, H. B., Veress, A. T., & Sonnenberg, H. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90370-2 · Cited by 3,148
Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., & Yasue, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115146 · Cited by 1,354
Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human
Burnett, J. C., Kao, P. C., Hu, D. C., Heser, D. W., Heublein, D., Granger, J. P., Opgenorth, T. J., & Reeder, G. S. (1986) · Science · doi:10.1126/science.2935937 · Cited by 891
Self-citationSelective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)
Koller, K. J., Lowe, D. G., Bennett, G. L., Minamino, N., Kangawa, K., Matsuo, H., & Goeddel, D. V. (1991) · Science · doi:10.1126/science.1672777 · Cited by 725
Effects of synthetic atrial natriuretic factor on renal function and renin release
Burnett, J. C. J., Granger, J. P., & Opgenorth, T. J. (1984) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1984.247.5.f863 · Cited by 659
Self-citationSuga, S., Nakao, K., Itoh, H., Komatsu, Y., Ogawa, Y., Hama, N., & Imura, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115933 · Cited by 529
Lerman, A., Gibbons, R. J., Rodeheffer, R. J., Bailey, K. R., McKinley, L. J., Heublein, D. M., & Burnett, J. C. (1993) · The Lancet · doi:10.1016/0140-6736(93)93125-k · Cited by 318
Self-citationC-TYPE NATRIURETIC PEPTIDE (CNP) IN RATS AND HUMANS
Komatsu, Y., Nakao, K., Suga, S.-I., Ogawa, Y., Mukoyama, M., Arai, H., Shirakami, G., Hosoda, K., Nakagawa, O., Hama, N., et al. (1991) · Endocrinology · doi:10.1210/endo-129-2-1104 · Cited by 296
Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.
Saito, Y., Nakao, K., Arai, H., Nishimura, K., Okumura, K., Obata, K., Takemura, G., Fujiwara, H., Sugawara, A., & Yamada, T. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113872 · Cited by 237
Chapeau, C., Gutkowska, J., Schiller, P. W., Milne, R. W., Thibault, G., Garcia, R., Genest, J., & Cantin, M. (1985) · Journal of Histochemistry & Cytochemistry · doi:10.1177/33.6.3158698 · Cited by 211
Plasma alpha natriuretic peptide in cardiac impairment.
Richards, A. M., Cleland, J. G., Tonolo, G., McIntyre, G. D., Leckie, B. J., Dargie, H. J., Ball, S. G., & Robertson, J. I. (1986) · BMJ · doi:10.1136/bmj.293.6544.409 · Cited by 168
Action of C-type natriuretic peptide in isolated canine arteries and veins
Wei, C., Aarhus, L. L., Miller, V. M., & Burnett, J. C. J. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.264.1.h71 · Cited by 148
Self-citationDistribution and characterization of immunoreactive porcine C-type natriuretic peptide
Ueda, S., Minamino, N., Aburaya, M., et al. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91631-l · Cited by 116
Natriuretic peptide receptor mRNAs in the rat and human heart.
Nunez, D. J., Dickson, M. C., & Brown, M. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116075 · Cited by 96
Cited by
Potter, L. R., Abbey-Hosch, S., & Dickey, D. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0014 · Cited by 1,002
Biochemical detection of left-ventricular systolic dysfunction
McDonagh, T., Robb, S., Murdoch, D., Morton, J., Ford, I., Morrison, C., Tunstall-Pedoe, H., McMurray, J., & Dargie, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03034-1 · Cited by 963
Colucci, W. S., Elkayam, U., Horton, D. P., Abraham, W. T., Bourge, R. C., Johnson, A. D., Wagoner, L. E., Givertz, M. M., Liang, C.-S., Neibaur, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430403 · Cited by 911
Spatial multi-omic map of human myocardial infarction
Kuppe, C., Ramirez Flores, R. O., Li, Z., Hayat, S., Levinson, R. T., Liao, X., Hannani, M. T., Tanevski, J., Wünnemann, F., Nagai, J. S., et al. (2022) · Nature · doi:10.1038/s41586-022-05060-x · Cited by 772
(2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432019 · Cited by 526
Metadata
- Authors
- Wei, C. M., Heublein, D. M., Perrella, M. A., Lerman, A., Rodeheffer, R. J., McGregor, C. G., Edwards, W. D., Schaff, H. V., & Burnett, J. C.
- Venue
- Circulation
- Published
- 1993-09
- Volume
- 88
- Issue
- 3
- Pages
- 1004-1009
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2161597738
- Cited by
- 460
- References
- 14
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.